Clinical Bibliography

View and download from our library of clinical trial articles and other publications. Opening PDFs requires Adobe^® Reader^® to be installed on your computer. Download Adobe's latest version of this free program here.

Articles

• Alexander HR, Butler CC. Development of isolated hepatic perfusion via the operative and percutaneous techniques for patients with isolated and unresectable liver metastases. Cancer J. 2010;16:132-141

• Pingpank JF, Libutti SK, Chang R, et al. Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol. 2005;23:3465-3474

• Seidel GD, Locklin J, Muehlbauer PM. Part I: regional chemotherapy clinical studies in nontraditional clinical settings. Clin J Oncol Nurs. 2006;10:338-344

• Muehlbauer PM, Klapec K, Locklin J, et al. Part II: nursing implications of administering chemotherapy in interventional radiology or the operating room. Clin J Oncol Nurs. 2006;10:345-356

• Beheshti MV, Denny DF, Glickman MG, et al. Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Interv Radiol. 1992;3:453-458

• Lowy AM, Curley SA. Clinical and preclinical trials of isolated liver perfusion for advanced liver tumors: primary liver tumors. Surg Oncol Clinics NA. 1996;5:429-441

• Ravikumar TS, Dixon MS. Ravikumar TS, Dixon MS. Isolated liver perfusion for liver metastases: pharmacokinetic advantage? Surg Oncol Clinics NA. 1996;5:443-449

• Ravikumar TS, Pizzorno G, Bodden W, et al. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol. 1994;12:2723-2736

• Curley SA, Newman RA, Dougherty T, et al. Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study. Ann Surg Oncol. 1994;1(5):389-399

• Curley SA, Byrd DR, Newman RA, et al. Reduction of systemic drug exposure following hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration. Surgery. 1993;114:579-585

Index of Abstracts

• Pingpank JF, Royal RE, Alexander HR, et al. Analysis of clinical toxicity in patients undergoing percutaneous intra-arterial hepatic perfusion (PHP) with melphalan for unresectable hepatic malignancies. World Conference on Interventional Oncology; 2007
  Presentation Slides   Abstract

• Burns WR, Royal RE, Libutti SK, et al. Percutaneous liver perfusion for patients with metastatic neuroendocrine tumors. International Symposium on Regional Cancer Therapies; 2007
  Poster

• Farma JM, Pingpank JF, Libutti SK, et al. Percutaneous hepatic perfusion (PHP) with melphalan for patients with metastatic melanoma (MM) to the liver. Society of Surgical Oncology; 2005
  Abstract

• Neeman Z, Wood BJ, Kam A, et al. Percutaneous hepatic perfusion for primary and secondary liver tumors—interventional radiology initial experience. Society of Interventional Radiology; 2004
  Abstract

• Pingpank JF, Libutti SK, Chang R, et al. A dose-escalation study of hepatic arterial melphalan infusion with hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. Gastrointestinal Cancers Symposium; 2004
  Abstract

• Pingpank JF, Libutti SK, Chang R, et al. A phase I feasibility study of hepatic arterial melphalan infusion with hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. American Society of Clinical Oncology; 2003
  Poster